Cannabis and arthritis pain: what the evidence does--and does not--show
Short answer: The sources checked do not establish that a cannabis product treats arthritis or its underlying disease. NCCIH summarizes some short-term chronic-pain studies, but those results cannot simply be relabeled as evidence for osteoarthritis or rheumatoid arthritis.
The evidence boundary
NCCIH describes trials of particular oral or under-the-tongue THC/CBD preparations for chronic pain. It says some may reduce pain over the short term, while dizziness and sleepiness can occur; little is known about other formulations or long-term use. Retail or dispensary products have not been shown by these studies to be equivalent to the tested formulations; this does not mean every such product is unregulated under local law. The evidence also does not show that cannabinoids slow joint damage or treat arthritis itself.
A systematic review of randomized trials searched through April 2015 and found only a small number of short studies in fibromyalgia and rheumatoid arthritis and no osteoarthritis trial meeting its criteria. The authors concluded evidence was insufficient to recommend a cannabinoid preparation for rheumatic-disease symptoms. Because that search is old, it is a historical evidence snapshot--not a complete review of all research available today.
A 2026 scoping review of osteoarthritis research included 19 studies published from 2020 onward. Early studies of varied CBD formulations suggest possible symptom relief, with topical CBD appearing promising, but product and dose variation and weak comparisons with standard pain treatments limit confidence. The authors concluded that the evidence does not justify routine clinical use. This newer review does not establish that cannabis treats arthritis or that a retail product is appropriate for an individual.
A useful question for an appointment
If pain is the reason for considering cannabis, ask a clinician or pharmacist whether any evidence applies to your diagnosis, current medicines, and the specific product being considered. Do not stop arthritis medicines or substitute an unapproved cannabis product based on this article.
For related context, see Medication interaction and safety questions.
Sources
- NCCIH: Chronic Pain and Complementary Health Approaches -- specific formulations, short-term evidence, and reported side effects.
- PubMed: systematic review of cannabinoids for rheumatic-disease pain (2016) -- older review with sparse arthritis trials and important evidence limits.
- FDA: Cannabis Research and Drug Approval Process -- approved medicines are distinct products for specific indications.
- Clinical Rheumatology: osteoarthritis scoping review (2026) -- 19 included studies, possible symptom signal, and limits that preclude routine clinical use.
This is a U.S.-scoped evidence summary, not a diagnosis, treatment recommendation, or individualized medical advice.
Quick answers
Do these sources show cannabis treats arthritis?
No. They summarize selected chronic-pain evidence, not proof that cannabis treats osteoarthritis, rheumatoid arthritis, or joint damage.
Do the studies apply to retail cannabis products?
Not automatically. Results concern particular formulations and limited study periods; they do not establish the effects of every retail product.